In wild-type p53 tumours, PARP-1 was associated with dedifferentiated tumour, and given the link between dedifferentiated tumours and the presence of CSCs cells [32], we next associated PARP-1 levels with different CSC marker levels. Here, PARP1 is linked to neoplasm.